Release Date: 26 June 2023
The field of biopharmaceuticals is witnessing an unprecedented revolution with the advent of tetraspecific antibodies. These innovative therapies have emerged as a promising solution to address unmet medical needs in a ra...
Release Date: 26 May 2023
Conventional drug delivery methods such as oral and intravenous infusions have been popular modes of drug delivery and have helped patients for a long time. However, these methods have proven to be ineffective when dealin...
Release Date: 24 May 2023
Lumakras was the first KRAS inhibitor to be granted approval by the FDA in 2021 post which it has been showing a continuous growth in its sales. From earning US$ 90 Million in 2021, Amgen earned US$ 285 Million in 2022, w...
Release Date: 21 May 2023
The field of antibody therapeutics has witnessed a remarkable breakthrough with the emergence of next generation antibodies. These innovative antibody formats including antibody drug conjugates, bispecific, trispecific an...
Release Date: 12 May 2023
Over the past couple of decades, immunotherapy has been a core part of the therapeutic landscape of cancer treatment. The introduction of immunotherapy in a complex disease like cancer has sparked the advancement of the m...
Release Date: 04 May 2023
Over the past few decades, China's pharmaceutical industry has evolved rapidly, especially in the area of antibodies research and development. An ageing population, growing healthcare costs, and an increase in the prevale...
Release Date: 27 April 2023
Undoubtedly, over the past decade, China has emerged as a rising star in the field of pharmaceutical research and development. Embracing a robust and rich pipeline of novel drug candidates and vigorous clinical activities...
Release Date: 24 April 2023
Cytotoxic T lymphocytes are an essential component of the body’s immunity against cancer, and agents that can stimulate the activation and proliferation of T cells form an ideal therapeutic strategy for the treatmen...
Release Date: 22 April 2023
Chinese biopharmaceutical company Akeso has attracted attention for its cutting-edge method of drug development. Several immune checkpoint inhibitor drugs made by Akeso are being tested in clinical trials to treat cancer....
Release Date: 22 April 2023
Immune checkpoint inhibition has become a common strategy for treating cancer, particularly solid tumors and the market success of the previously approved immune checkpoint inhibitors has stimulated the development of mor...
Release Date: 22 April 2023
Advancements in technology used in the pharmaceutical domain have enabled the development of several novel medicines and therapies having mechanisms unanticipated before. An example of this is Talquetamab, an antibody targeting GPRC5D, a...
Release Date: 22 April 2023
Since they were introduced in the market for the treatment of different diseases, bispecific antibodies have changed the treatment landscape for cancer and some other diseases. However, they have had the most profound eff...
Release Date: 04 April 2023
Conventional treatment approaches like chemotherapy, surgery and radiation have been the pillars of cancer treatment for decades. As research progressed, more novel and non-invasive methods to treat cancer were developed ...
Release Date: 03 April 2023
Tumor-infiltrating lymphocyte therapy has been gaining popularity in the last few years thanks to the regulatory milestones achieved by some candidates currently in development or under clinical evaluation. With adoptive ...
Release Date: 31 March 2023
Bispecific antibodies have transformed the landscape of cancer treatment in the last decade, with as many as 10 bispecific antibodies having gained approval in different parts of the world in the last 8 years. Out of all ...